Finance
Apex Bio-Solutions Completes $1.2 Billion Acquisition of Rival Genetica, Boosting Gene Therapy Pipeline.
Apex Bio-Solutions announced its successful acquisition of Genetica Inc., a move valued at $1.2 billion in cash and stock
24 November 2025 - 21:55
Jake Gyllenhaal
Gary Oldman
Apex Bio-Solutions Completes $1.2 Billion Acquisition of Rival Genetica, Boosting Gene Therapy Pipeline.
The strategic rationale behind the Apex-Genetica merger extends beyond simply acquiring pipelines; it is a defensive move to consolidate market position against emerging pharmaceutical giants entering the gene therapy space. The $1.2 billion price tag reflects the high premium placed on Genetica's p
news business
center
Health
Staffing Crisis: County Hospital Announces Limited Services Due to Severe Nursing Shortage.
center
Education
Mountain View High Wins Prestigious State Grant for Cutting-Edge Robotics and AI Lab.
© Torino Post · Tutti i diritti riservati